Immunology News and Research

Latest Immunology News and Research

Suicidal teens not getting needed mental healthcare

Suicidal teens are not likely to get the mental healthcare they need. This is according to a team of researchers at Seattle Children's Research Institute, the University of Washington (UW), and Group Health Research Institute. The study, "Adolescents With Suicidal Ideation: Health Care Use and Functioning," was recently published in Academic Pediatrics.

14 Sep 2011

Combining cell biology and molecular genetics for single-cell research

Fluidigm Corporation has announced a collaboration with BD Biosciences, a segment of BD (Becton, Dickinson and Company), to co-host a public seminar series on the isolation and analysis of single cells. Entitled 'A Powerful Technique for Single-Cell Analysis', the public seminar series will showcase cell isolation using the BD FACSAria™ III Cell Sorter and analysis using the Fluidigm BioMark™ HD System.

13 Sep 2011

Work intensity of physicians across several specialties is fairly equal: Study

Contrary to longstanding assumptions, new findings suggest the work intensity of physicians across several specialties is fairly equal. The study, funded by the American Academy of Neurology along with several other medical associations and published online ahead of print in the journal Medical Care, provides the groundwork for the development of a more reliable, scientific measurement of physician work intensity that may guide future national policy in patient safety, practice management and payment.

12 Sep 2011

UMSOM to receive FDA approval for whole parasite malaria vaccine clinical trials

For the first time, a malaria vaccine that uses the entire malaria parasite has proven safe and shown promise to produce a strong immune response in a clinical trial, according to a new study co-authored by researchers at the University of Maryland School of Medicine Center for Vaccine Development.

12 Sep 2011

Landmark discovery in rapid spread of PRL-3 oncoprotein associated aggressive cancers

Scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) have made a landmark discovery in the battle against the rapid spread of aggressive cancers associated with PRL-3 oncoprotein.

9 Sep 2011

UC research: Physicians report similar degrees of work intensity

Although society's perception might be that surgeons endure greater mental challenges and stress in their work duties than a primary care doctor, new research from experts at the University of Cincinnati (UC) shows that this isn't necessarily the case.

9 Sep 2011

Cardiovascular and Renal Drugs Advisory Committee recommends FDA approval of J&JPRD's rivaroxaban

Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD) announced today that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee recommended approval of rivaroxaban, a novel, once-daily, oral anticoagulant, for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.

9 Sep 2011

Abnormal levels of lysophosphatidic acid can trigger congenital hydrocephalus

Scientists at The Scripps Research Institute have found what may be a major cause of congenital hydrocephalus, one of the most common neurological disorders of childhood that produces mental debilitation and sometimes death in premature and newborn children.

8 Sep 2011

Tick-borne disease in US blood supply

A tick-borne infection known as Babesiosis, which can cause severe disease and even death, is becoming a growing threat to the U.S. blood supply, government researchers said on Monday.

6 Sep 2011

Youth immunization rates encouraging: CDC report

According to a survey by the Centers for Disease Control and Prevention (CDC) out Monday, more and more American adolescents are receiving recommended vaccines.

6 Sep 2011

Einstein researchers develop tuberculosis vaccine candidate

Researchers at Albert Einstein College of Medicine of Yeshiva University report in the September 4 online edition of Nature Medicine that they have developed a tuberculosis (TB) vaccine candidate that proved both potent and safe in animal studies.

5 Sep 2011

Researchers discover protein signals responsible for preserving anti-viral antibodies

Our immune system is capable of a remarkable feat: the ability to remember infections for years, even decades, after they have first been encountered and defeated. While the antibodies we make last only about a month, we retain the means of making them for a lifetime.

3 Sep 2011

Plerixafor drug shows promise against WHIM syndrome

A new study reports that a drug already approved by the Food and Drug Administration for use in patients undergoing a bone marrow transplant may also have promise for treating people who have a rare immune deficiency known as WHIM syndrome.

3 Sep 2011

UVA researchers develop 3-D model to visualize early growth of human breast tissue

University of Virginia researchers have developed a revolutionary three-dimensional model that allows them to visualize how breast tissue grows in its earliest stages, giving them the closest look ever at the very beginnings of breast cancer.

2 Sep 2011

CRI announces winners of 2011 Coley Award for distinguished research in tumor immunology

The Cancer Research Institute, Inc. (CRI), a U.S. nonprofit organization established in 1953 to advance the science of tumor immunology and drive the discovery of new cancer immunotherapies, announced today the winners of the 2011 William B. Coley Award for Distinguished Research in Tumor Immunology.

2 Sep 2011

Infant rotavirus vaccination may provide indirect protection to older children, adults in the U.S.

Vaccinating infants against rotavirus also prevents serious disease in unvaccinated older children and adults, according to a study by the Centers for Disease Control and Prevention.

31 Aug 2011

Study may help explain plague's rapid evolution and aid in development of therapeutics

In the evolutionary blink of an eye, a bacterium that causes mild stomach irritation evolved into a deadly assassin responsible for the most devastating pandemics in human history. How did the mild-mannered Yersinia pseudotuberculosis become Yersinia pestis, more commonly known as the Plague?

30 Aug 2011

FDA advisory committee postpones Panel review of Gen-Probe's PROGENSA PCA3 Assay

DiagnoCure, Inc., a life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that Gen-Probe Incorporated, its commercial partner for the PCA3 test, received notice from the U.S. Food and Drug Administration (FDA) that the PROGENSA PCA3 Assay will not be reviewed by the Immunology Panel of FDA's Medical Devices Advisory Committee on October 14, 2011 as previously scheduled, but will be reviewed by the Panel at a later date.

30 Aug 2011

New chemical compounds show promise against set of protein-folding diseases

Collaborating researchers at Stanford University and The Scripps Research Institute have identified chemical compounds that show promise as potential therapeutics for a set of medical conditions caused by the abnormal clumping together of a protein known as transthyretin.

30 Aug 2011

Vitamin A supplements in children could save up to 600,000 lives a year: Study

Researchers have found that giving vitamin A supplements to children under the age of five in developing countries could save up to 600,000 lives a year. Writing in the British Medical Journal, UK and Pakistani experts assessed 43 studies involving 200,000 children, and found deaths were cut by 24% if children were given the vitamin. They add that it would also cut rates of measles and diarrhea.

30 Aug 2011

Immunology News and Research

Latest Immunology News and Research

Suicidal teens not getting needed mental healthcare

Combining cell biology and molecular genetics for single-cell research

Work intensity of physicians across several specialties is fairly equal: Study

UMSOM to receive FDA approval for whole parasite malaria vaccine clinical trials

Landmark discovery in rapid spread of PRL-3 oncoprotein associated aggressive cancers

UC research: Physicians report similar degrees of work intensity

Cardiovascular and Renal Drugs Advisory Committee recommends FDA approval of J&JPRD's rivaroxaban

Abnormal levels of lysophosphatidic acid can trigger congenital hydrocephalus

Tick-borne disease in US blood supply

Youth immunization rates encouraging: CDC report

Einstein researchers develop tuberculosis vaccine candidate

Researchers discover protein signals responsible for preserving anti-viral antibodies

Plerixafor drug shows promise against WHIM syndrome

UVA researchers develop 3-D model to visualize early growth of human breast tissue

CRI announces winners of 2011 Coley Award for distinguished research in tumor immunology

Infant rotavirus vaccination may provide indirect protection to older children, adults in the U.S.

Study may help explain plague's rapid evolution and aid in development of therapeutics

FDA advisory committee postpones Panel review of Gen-Probe's PROGENSA PCA3 Assay

New chemical compounds show promise against set of protein-folding diseases

Vitamin A supplements in children could save up to 600,000 lives a year: Study

eBook: Cell-based technologies in drug discovery and Immunotherapy eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey